Harvard Bioscience, Inc. · NASDAQ:HBIO
Eade Katherine A. received 16,556 Harvard Bioscience, Inc. shares as an award (Form 4)
Traded Jun 9, 2026 · Filed Jun 12, 2026
On Jun 9, 2026, Eade Katherine A. (Director) received 16,556 Harvard Bioscience, Inc. shares as an award, leaving 58,669 shares. Filed Jun 12, 2026 (Form 4).
- Awarded
- 16,556 shares
- Holding after
- 58,669 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | Award | 16,556 | 58,669 | Direct |